A B S T R A C T Intact diaphragms from vitamin D-deficient rats were incubated in vitro with ['H]leucine. Oral administration of 10 ug (400 U) of cholecalciferol 7 h before incubation increased leucine incorporation into diaphragm muscle protein by 136% (P <0.001) of the preparation from untreated animals. Nephrectomy did not obliterate this response. ATP content of the diaphragm muscle was also enhanced 7 h after administration of the vitamin. At 4 h after administration of cholecalciferol, serum phosphorus concentration was reduced by 0.7 mg/100 ml (P <0.025) and the rate of inorganic 'PO. accumulation by diaphragm muscle was increased by 18% (P < 0.025) over the untreated animals. Increasing serum phosphate concentration of the vitamin D-deficient animals by dietary supplementation with phosphate for 3 days failed to significantly enhance leucine incorporation into protein. However, supplementation of the rachitogenic, vitamin D-deficient diet with phosphorus for 3 wk stimulated the growth of the animal and muscle ATP levels. This increase in growth and muscle ATP content attributed to the addition of phosphorus to the diet was less than the increase in growth and muscle ATP levels achieved by the addition of both phosphorus and vitamin D to the diet.
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INTRODUCTION
Stimulation of growth of the vitamin D-deficient patient or experimental animal has long been a recognized response to vitamin D replacement therapy (1) (2) (3) . This increase in musculoskeletal growth has been attributed to the specific action of vitamin D on calcium homeostasis and specifically, the increase in intestinal absorption of calcium and secondarily an increase in bone mineralization and growth (4, 5) . More recently a direct action of vitamin D on bone has been recognized which is characterized by the stimulation of osteoclastic bone resorption (6) . The role of vitamin D in mineral homeostasis has more recently been extended to include the action of the vitamin in the mobilization of phosphate from the intestine (7-9) and other tissues (10) . The stimulation of intestinal calcium and phosphorus transport both appear to be mediated by the 1,25-dihydroxy metabolite of vitamin D synthesized by the kidneys (11, 12 ) from 25-hydroxycholecalciferol (25-OHD3)' which is derived from the hepatic hydroxylation of vitamin D3 (13) . The earlier reported failure of orally administered 1,25-dihydroxycholecalciferol (1,25- (OH)2Da) to cure the rachitic state in rats (14) has now been attributed to the more rapid clearance of 1,25-(OH)2Ds relative to its immediate precursor, 25-OHD8 (15) , which was effective in this regard. Accordingly, the 1,25-dihydroxy metabolite of cholecalciferol is considered to be the physiologically active form of the vitamin in mediating the mobilization of calcium and phosphorus from the intestine and bone.
However, in addition to the skeletal lesion and intestinal transport defects, muscle weakness and atrophy are also prominent features of nutritional vitamin D deficiency (16) (17) (18) (19) . Vitamin D replacement therapy rapidly reverses these often incapacitating manifestations of the deficiency state. The influence of vitamin D on muscle metabolism and growth has not been specifically examined although two decades ago Steenbock and Herting (1) suggested on the basis of their nutritional studies that vitamin D may have a "widespread effect on organic tissue metabolism of which increased growth is merely one manifestation." Evidence is presented in this report of a direct action of 25-OHD3 on muscle metabolism and muscle protein synthesis which is independent of the action of vitamin D and its metabolites on intestinal calcium and phosphorus absorption.
METHODS
Preparation of animals. Male Wistar rats, 3 wk of age, were maintained for 4 wk on a synthetic diet described by Kenny and Munson (20) from which vitamin D, calcium, and phosphorus salts could be omitted. All animals were maintained on this diet containing 1.5% calcium, 0.1%o phosphorus, and no vitamin D. To insure the availability of adequate phosphate to the tissues, the phosphorus content was increased from 0.1%o to 0.4%o 4 days before sacrifice unless stated otherwise. Vitamin D, 10 Atg in cotton seed oil, or cotton seed oil alone was administered by oral intubation at varying time intervals before sacrifice. At a dose of 0.4 iug per animal, 25-OHD3 was administered intravenously in 0.1 cm' of vitamin D-deficient rat serum. These doses of the vitamin were selected because they generated physiologic concentrations of 25-OHD3 in serum at 7 h. Animals used for epitrochlear muscle incubations were also maintained on the synthetic diet with 1.5% calcium, 0.1% phosphorus, and without vitamin D.
Diaphragm studies. Animals were sacrificed by decapitation and the diaphragms quickly removed intact connected to the rib cage. The diaphragm was then divided through the midline connective tissue without cutting the muscular portion, then placed into stoppered 25-ml Erlenmeyer flasks gassed with 95% oxygen, 5% C02. The composition of the incubation medium is presented in Table I (21) . In determining the (24) and the serum phosphorus concentration was determined colorimetrically (25) . A competitive proteinbinding assay (26) was used to measure serum concentrations of 25-OHD3. Epitrochlear muscle studies. The epitrochlear muscle of the foreleg was excised at its tendinous insertions from the exposed limb with care taken not to injure the muscle. Control and vitamin-treated incubations were carried out on paired muscles from the same animals. The conditions of the incubation were the same as those for the diaphragm muscle studies with the exception of the addition of 10% vitamin D-deficient rat serum. The latter served as a vehicle for the addition of vitamin D and its metabolites to the incubation. The procedure for the preparation of the muscle for protein and radioactivity measurements was the same as that described for diaphragm muscle. Incor (Table III) . Thus the increased incorporation of ['H]leucine into protein cannot be attributed to an increased accumulation of the isotope within the cell.
In addition to changes in certain parameters of muscle metabolism, unexpected changes in serum phosphorus were observed (Table IV) . At 7 h after administration of vitamin D, serum phosphorus of vitamin-treated animals was significantly greater (P <0.01) than untreated control animals, consistent with the observations of Chen et al. (10) . At 7 h, circulating concentrations of 25-OHD3 were 16±3 ng/ml for this metabolite of vitamin D. This compares to a 25-OHD3 level of 11.4-+-1.7 (SD) ng/ml in normal rats on Purina rat chow. At 4 h after administration of 10 lg of vitamin D, circulating concentrations of 25-OHD3 were 5±1 ng/ml, and the concentration of the serum phosphorus was now significantly reduced (P < 0.025) in the vitamin-treated animals. These data suggest that the first demonstrable Table VII . In these studies the dietary intake of calcium was adjusted to provide a similar serum concentration of calcium in an effort to minimize the influence on growth of this cation. The four groups of animals were pair-fed their respective diets for 3 wk. Over the 3-wk period the addition of phosphate to the diet accelerated growth both in the presence and absence of vitamin D, although maximal growth was achieved with the addition of both vitamin D and phosphorus to the diets. The rate of growth was correlated with the concentration of serum phosphate but not the level of ATP in muscle.
To further establish the mechanism of vitamin D stimulation of muscle metabolism, the epitrochlear muscle of the forelimb of the rachitic rat was studied in tissue culture. Thus muscle is flat with a uniform thickness of approximately 500 Am and can easily be removed without damage to the body of the muscle. These properties facilitate the maintenance of the tissue in culture. Linear rates of [8H] leucine incorporation into protein were observed for 5 h in culture. Addition of 25-OHD3 at a concentration of 20 ng/ml, the approximate physiologic concentration of this metabolite of vitamin D in man and rat, stimulated the incorporation of [3H]leucine into protein and increased the ATP content of the muscle (Table VIII) . The parent vitamin, cholecalciferol, at 1,000 times this concentration was without effect. Finally, 1,25-(OH)2D3, at a concentration of 0.5 ng/ml and therefore at a concentration considerably greater than the estimated concentration of this biologically active metabolite in the circulation, also failed to stimulate protein synthesis and the accumulation of ATP in the muscle preparation.
The biologic potency of the 1,25-(OH)2D3 used in these studies was established by demonstrating the ability of this preparation of 1,25-(OH)2DI at a concentration of 50 pg/ml to stimulate the incorporation of 'Ca into chick intestinal explants maintained in culture.
In contrast to the 4.1S sedimentation of 'H on sucrose gradients when radioactive 25 (Table IX) . Since rat serum trations are normally 2-4 X 10' M, the muscle is normally perfused by a concentration of is in excess of the concentration at which half of the muscle cytosol sites are occupied.
DISCUSSION
The influence of vitamin D on intestinal transport of calcium and phosphorus and the influence of the vitamin on the maintenance of normal skeletal growth have been well established (1) (2) (3) (4) (5) (6) (8) (9) (10) . Although muscle wasting and weakness are prominent features of nutritional rickets (16) (17) (18) (19) , a direct action of the vitamin on muscle metabolism and growth has heretofore not been appreciated. The generalized growth failure characteristic of vitamin D deficiency has previously been attributed to the failure of skeletal growth and the disordered calcium and phosphorus homeostasis attributed to the action of the vitamin on intestinal transport of these ions (4, 5 The apparent specificity of the muscle response to 25-OHD3 and the failure of the muscle to respond to physiologic concentrations of 1,25-(OH) 2D3 is of obvious interest. This biologic specificity for 25-OHD3 is supported by the finding of a muscle cytosol protein fraction which specifically binds 25-OHD3. The Koq of this binding to the cytosol protein fraction (5 X 10"1 M) is significantly less than the concentration of in the circulation (2-4 X 10' M) to which the muscle would be exposed. Furthermore 1,25-(OH)2D3 demonstrated a significantly lesser affinity for this protein, again consistent with the failure of physiologic concentrations of 1,25-(OH)2D3 to alter muscle protein synthetic processes. These observations do not exclude the presence of a specific receptor protein for 1,25-(OH)2D3 and a biologic response of muscle other than the parameters measured. Previously we reported that a wide variety of tissues demonstrated similar binding characteristics for 25-OHD3 (31). The question is then raised as to whether this metabolite of vitamin D plays a similar role in the metabolism of these tissues and that therefore the primary action of this metabolite of vitamin D may be the generalized maintenance of cell growth and function.
